𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparative analysis of quality of life data from a Southwest Oncology Group randomized trial of advanced colorectal cancer

✍ Scribed by Andrea B. Troxel


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
105 KB
Volume
17
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis


Longitudinal quality of life measurements from an advanced-stage cancer clinical trial are analysed using a variety of methods, and the results compared. The methods used require di erent assumptions about the mechanism that produces the missing data. They include analyses that require the data to be missing completely at random; ΓΏxed-e ects models and weighted generalized estimating equations, which require missing at random data; and a fully parametric approach where the outcomes and the missingness mechanism are jointly modelled, allowing non-ignorable missing data. The data show evidence of non-random missingness, but a formal test of non-ignorable missing data is not signiΓΏcant.


πŸ“œ SIMILAR VOLUMES


The effects of radiation therapy on qual
✍ Timothy J. Whelan; Mark Levine; Jim Julian; Peter Kirkbride; Peter Skingley; Ont πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

## BACKGROUND. The purpose of this study was to evaluate the effect of breast irradiation on quality of life, including cosmetic outcome, for patients enrolled in a clinical trial. ## METHODS. Between 1984 and 1989, a randomized trial was conducted in Ontario, Canada, in which women with lymph no

Prospective randomized reappraisal of 5-
✍ Cary A. Presant; Alex E. Denes; Charlene Liu; Alfred A. Bartolucci; The Southeas πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 2 views

In order to redefine the effectiveness of 5-fluorouracil (5-FU) as palliative therapy in patients with metastatic colorectal carcinoma, and to compare the effectiveness of 6-thioguanine (6-TG) with that of 5-FU, we studied 176 patients with metastatic colorectal carcinoma in a randomized prospective

The combination of cisplatin, doxorubici
✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 482 KB πŸ‘ 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat